Tildacerfont-d8 (SPR001-d8) is a deuterium labeled Tildacerfont (HY-113603). Tildacerfont is a potent and orally active corticotrophin-releasing factor type 1 (CRF1) receptort antagonis. Tildacerfont effectively reduces adrenocorticotropic hormone (ACTH) and adrenal androgen levels. Tildacerfont has favourable safety profile. Tildacerfont can be used for researching congenital adrenal hyperplasia[1].
Molecular Weight:
428.02
Purity:
99.68
CAS Number:
[2762751-36-8]
Formula:
C20H18D8ClN5OS
Target:
CRFR,Isotope-Labeled Compounds
Application Notes:
MCE Product type: Isotope-Labeled Compounds
* VAT and and shipping costs not included. Errors and price changes excepted